Literature DB >> 22612068

Infantile osteoma cutis as a presentation of a GNAS mutation.

John Martin1, Melissa Tucker, John C Browning.   

Abstract

We report a case of osteoma cutis associated with a GNAS mutation in a 7-month-old boy. The patient displayed no other laboratory or physical abnormalities to suggest other GNAS-associated disorders of cutaneous ossification, including Albright's hereditary osteodystrophy or pseudohypoparathyroidism 1A, although a history of intrauterine growth restriction was troubling for progressive osseous heteroplasia. A review of the clinical and laboratory manifestations of these disorders is discussed, as well as differentiating features.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22612068     DOI: 10.1111/j.1525-1470.2011.01469.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  5 in total

1.  Plate-like osteoma cutis: nothing but skin and bone?

Authors:  Inês Coutinho; V Teixeira; J C Cardoso; J P Reis
Journal:  BMJ Case Rep       Date:  2014-05-05

Review 2.  An update on the clinical and molecular characteristics of pseudohypoparathyroidism.

Authors:  Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

Review 3.  GNAS mutations and heterotopic ossification.

Authors:  Murat Bastepe
Journal:  Bone       Date:  2017-09-06       Impact factor: 4.398

4.  Identification of a novel mutation in a patient with pseudohypoparathyroidism type Ia.

Authors:  Ye Seung Lee; Hui Kwon Kim; Hye Rim Kim; Jong Yoon Lee; Joong Wan Choi; Eun Ju Bae; Phil Soo Oh; Won Il Park; Chang Seok Ki; Hong Jin Lee
Journal:  Korean J Pediatr       Date:  2014-05-31

Review 5.  Epidemiology and Diagnosis of Hypoparathyroidism.

Authors:  Bart L Clarke; Edward M Brown; Michael T Collins; Harald Jüppner; Peter Lakatos; Michael A Levine; Michael M Mannstadt; John P Bilezikian; Anatoly F Romanischen; Rajesh V Thakker
Journal:  J Clin Endocrinol Metab       Date:  2016-03-04       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.